These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 16257156)

  • 1. Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies.
    Gavini E; Hegge AB; Rassu G; Sanna V; Testa C; Pirisino G; Karlsen J; Giunchedi P
    Int J Pharm; 2006 Jan; 307(1):9-15. PubMed ID: 16257156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
    Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
    J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide.
    Gavini E; Rassu G; Muzzarelli C; Cossu M; Giunchedi P
    Eur J Pharm Biopharm; 2008 Feb; 68(2):245-52. PubMed ID: 17574825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spray-dried carbamazepine-loaded chitosan and HPMC microspheres: preparation and characterisation.
    Filipović-Grcić J; Perissutti B; Moneghini M; Voinovich D; Martinac A; Jalsenjak I
    J Pharm Pharmacol; 2003 Jul; 55(7):921-31. PubMed ID: 12906749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes.
    Gungor S; Okyar A; Erturk-Toker S; Baktir G; Ozsoy Y
    Drug Dev Ind Pharm; 2010 Jul; 36(7):806-13. PubMed ID: 20136490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of mucoadhesive microspheres for nasal delivery of ketorolac.
    Nagda CD; Chotai NP; Nagda DC; Patel SB; Patel UL
    Pharmazie; 2011 Apr; 66(4):249-57. PubMed ID: 21612151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of clozapine through chitosan microparticles prepared by a novel method.
    Agnihotri SA; Aminabhavi TM
    J Control Release; 2004 Apr; 96(2):245-59. PubMed ID: 15081216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan microspheres of aceclofenac: in vitro and in vivo evaluation.
    Nagda C; Chotai N; Patel S; Nagda D; Patel U; Soni T
    Pharm Dev Technol; 2010; 15(5):442-51. PubMed ID: 20735299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
    Huang YC; Chiang CH; Yeh MK
    J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres.
    Abdel Mouez M; Zaki NM; Mansour S; Geneidi AS
    Eur J Pharm Sci; 2014 Jan; 51():59-66. PubMed ID: 23999035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of magnesium stearate on chitosan microspheres prepared by an emulsification-coacervation technique.
    Lim LY; Wan LS
    J Microencapsul; 1998; 15(3):319-33. PubMed ID: 9608395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of carbamazepine-loaded enteric microparticles.
    Dong WY; Maincent P; Bodmeier R
    Int J Pharm; 2007 Feb; 331(1):84-92. PubMed ID: 17081708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.
    Mutalik S; Anju P; Manoj K; Usha AN
    Int J Pharm; 2008 Feb; 350(1-2):279-90. PubMed ID: 17945447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone.
    al-Helw AA; Al-Angary AA; Mahrous GM; al-Dardari MM
    J Microencapsul; 1998; 15(3):373-82. PubMed ID: 9608399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
    Wittaya-areekul S; Kruenate J; Prahsarn C
    Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochloride.
    Huh Y; Cho HJ; Yoon IS; Choi MK; Kim JS; Oh E; Chung SJ; Shim CK; Kim DD
    Eur J Pharm Sci; 2010 Apr; 40(1):9-15. PubMed ID: 20149868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
    Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K
    Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of prednisolone acetate-loaded chitosan microspheres using a 2(3) factorial design for preventing restenosis.
    Sarisözen C; Arica B; Orman MN; Hincal AA; Caliş S
    Drug Deliv; 2010 Apr; 17(3):178-86. PubMed ID: 20196705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpenetrating polymer network blend microspheres of chitosan and hydroxyethyl cellulose for controlled release of isoniazid.
    Angadi SC; Manjeshwar LS; Aminabhavi TM
    Int J Biol Macromol; 2010 Aug; 47(2):171-9. PubMed ID: 20471411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, characterization and in vitro evaluation of 5-aminosalicylic acid loaded N-succinyl-chitosan microparticles for colon specific delivery.
    Mura C; Nácher A; Merino V; Merino-Sanjuán M; Manconi M; Loy G; Fadda AM; Díez-Sales O
    Colloids Surf B Biointerfaces; 2012 Jun; 94():199-205. PubMed ID: 22341520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.